Companies · Other Health Care
BOSTON · Other Health Care
Diligence memoA one-page analyst read on Genoa-QoL Investment Holdings, LP — recommendation, valuation, rhythm, risks.→Genoa-QoL Investment Holdings, LP looks under-valued against its niche peers and is dormant on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
Genoa-QoL Investment Holdings, LP behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
Genoa-QoL Investment Holdings, LP is one of 5377 Other Health Care companies tracked from BOSTON. By capital raised it ranks mid-pack (ahead of 58% of sector peers), and in the long tail by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.
Round size and date are reported; the stage label is inferred from round size (latest is Seed — a $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.
Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 58% of sector peers (real $). Modeled value above 39% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #204 of 222.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Eye Academy of America Ltd. | Seed | $4.0M | $99.1M | 2.23× |
| Ruddco Inc. | Seed | $4.0M | $99.1M | 2.23× |
| Guest House Holdings, LLC | Seed | $4.0M | $99.1M | 2.23× |
| Cb Therapeutics Inc. | Seed | $4.0M | $99.1M | 2.23× |
| Shift Sciences, LLC | Seed | $4.0M | $98.6M | 2.22× |
| BHCP OK4 HH/H Investors, LLC | Seed | $4.0M | $97.9M | 2.21× |
| ReNovo, Inc. | Seed | $4.0M | $97.9M | 2.21× |
| CCRC of Lenexa, LLC | Seed | $3.9M | $97.6M | 2.20× |
| Nocira, Llc | Seed | $3.9M | $96.7M | 2.18× |
| PureFlowCath, LLC | Seed | $3.8M | $94.6M | 2.13× |
| Prevent Biometrics, Inc. | Seed | $4.2M | $94.2M | 2.12× |
| Medal, Inc. | Seed | $3.8M | $93.6M | 2.11× |
| Genoa-QoL Investment Holdings, LP this company | Seed | $3.6M | $12.4M | 0.28× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Seed | $3.1M | 2015-11-02 | $15.5M | $76.8M | 90% |
| Seed | $500K | 2016-04-18 | $2.5M | $12.4M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Mark Peterson | — | 4 other | 2015-11 |
| Christopher Crosby | — | 1 other | 2015-11 |
| Douglas Present | — | 1 other | 2015-11 |
| John Figueroa | — | 1 other | 2015-11 |
| JOHN MALDONADO | — | 1 other | 2015-11 |
| Victor Breed | — | 1 other | 2015-11 |
| CARMINE PETRONE | — | — | 2015-11 |
| CHRISTOPHER PIKE | — | — | 2015-11 |
| DAVE VUCUREVICH | — | — | 2015-11 |
Genoa-QoL Investment Holdings, LP is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| QoL meds Holding Company, LLC | Other | Series C | $84.0M | $1.4B | network4 shared operators |
| Ichor Vascular Inc. | Other Health Care | Seed | $3.1M | $15.7M | network1 shared operator · same sector · same stage |
| VenX, LLC | Other Health Care | Seed | $3.7M | $10.3M | same sector · same stage |
| Proa Medical, Inc. | Other Health Care | Seed | $3.5M | $13.5M | same sector · same stage |
| Truelastin Laboratories, Inc. | Other Health Care | Seed | $3.5M | $13.5M | same sector · same stage |
| Vymedic Inc. | Other Health Care | Seed | $3.5M | $10.3M | same sector · same stage |
| Othership Inc. | Other Health Care | Seed | $3.7M | $11.1M | same sector · same stage |
| Arrellio, Inc. | Other Health Care | Seed | $3.5M | $10.0M | same sector · same stage |
See where Genoa-QoL Investment Holdings, LP sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Genoa-QoL Investment Holdings, LP, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.